HR4299Referred to Committee

Protecting Patient Access to Cancer and Complex Therapies Act

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-07
Introduced
55
Cosponsors
HR
ⓘ
Type

Sponsor

Gregory F. Murphy
Gregory F. Murphy
Republican · NC · Representative
Votes with party: 98.6% (587 recorded votes)

Full profile: /officials/M001210

Source: Congress.gov · FEC

Cosponsors (55)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

2025-07-07

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would protect patients' ability to access cancer treatments and other complex medications by limiting insurance companies' ability to deny or delay coverage for these therapies. It likely aims to reduce barriers that patients face when their doctors prescribe specialized drugs, such as requiring prior approval from insurers before treatment can begin. The measure would affect cancer patients, people with rare diseases, insurance companies, and healthcare providers.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.